XRN-PB

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Total revenue 34.62 M37.97 M37.23 M38.39 M38.06 M 151.65 M Gross profit 34.62 M37.97 M37.23 M38.39 M38.06 M 151.65 M Operating expenses 15.05 M18.56 M17.17 M18.84 M17.75 M 72.33 M Selling/general/admin expenses 3.62 M6.03 M4.86 M5.49 M5.09 M 21.47 M Research & development ————— — Operating income 19.57 M19.41 M20.05 M19.55 M20.31 M 79.33 M Non-Operating Income, Total ————-7.23 M — Interest expense, net of interest capitalized 7.17 M8.01 M8.18 M8.4 M7.23 M 31.82 M Non-Operating Income, excl. Interest Expenses ————-14.47 M — Unusual income/expense ————— — Pretax income 27.15 M27.63 M28.28 M28.14 M29.56 M 113.61 M Equity in earnings ————— — Taxes ————— — Non-controlling/minority interest 178 K-70 K-512 K-643 K-70 K -1.29 M After tax other income/expense -25 K-45 K-24 K-53 K53 K -69 K Net income before discontinued operations 3.74 M585 K-5.06 M-6.15 M1.65 M -8.97 M Discontinued operations 1.36 M207 K294 K-372 K— — Net income 3.74 M585 K-5.06 M-6.15 M1.65 M -8.97 M Dilution adjustment -178 K70 K512 K643 K70 K 1.29 M Preferred dividends 1.46 M1.46 M1.46 M1.92 M2.47 M 7.3 M Diluted net income available to common stockholders 2.1 M-800 K-6 M-7.42 M-749 K -14.97 M Basic earnings per share (Basic EPS) 0.15-0.05-0.45-0.57-0.06 -1.13 Diluted earnings per share (Diluted EPS) 0.17-0.05-0.45-0.57-0.06 -1.13 Average basic shares outstanding 13.37 M13.38 M13.39 M13.38 M13.23 M — Diluted shares outstanding 13.37 M13.38 M13.39 M13.38 M13.23 M — EBITDA 33.39 M34.7 M35.06 M34.46 M35.14 M 139.37 M EBIT 19.57 M19.41 M20.05 M19.55 M20.31 M 79.33 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 13.83 M15.29 M15.01 M14.92 M14.83 M 60.04 M